Congress member disclosure profile
Loading receipt-linked disclosure rows from source filings…
Receipt-backed STOCK Act disclosure
As of July 18 at 5:02 AM EDT
Buy · Nov 13, 2020
Teva Pharmaceutical Industries limited American depositary Shares. This page identifies a public filing and does not imply motive, causation, or wrongdoing.
Amount range
$15,001 to $50,000
Owner
Joint
Filed
Feb 14, 2020
Filing delay
0 days · within the 45-day window
Receipt
Clerk filing 20017780
Same-window market context
Comparable TEVA and SPY closes are not available on identical dates for this transaction window.
Receipt-qualified trades in the same tickers by other congressional filers.
David E. Price · Sell TEVA
Jun 19, 2019 · Receipt pending ingestion
Cheri Bustos · Sell TEVA
Jan 30, 2017 · $1,001 to $15,000
K. Michael Conaway · Sell TEVA
Sep 12, 2016 · $1,001 to $15,000
K. Michael Conaway · Sell TEVA
May 11, 2016 · $1,001 to $15,000
K. Michael Conaway · Sell TEVA
May 4, 2016 · $1,001 to $15,000
Alan S. Lowenthal · Sell TEVA
Sep 11, 2015 · $15,001 to $50,000
One source-linked summary each week. Confirm by email; unsubscribe anytime.
Official receipt
Embedded from the source filing. Use the direct link if your browser blocks PDF embeds.